In yesterday’s Wall Street session, Avantor Inc. (NYSE:AVTR) shares traded at $20.88, up 3.32% from the previous session.
19 analysts cover Avantor Inc. (NYSE:AVTR), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $33.00 and a low of $23.00, we find $27.00. Given the previous closing price of $20.21, this indicates a potential upside of 33.6 percent. AVTR stock price is now 0.41% away from the 50-day moving average and -27.09% away from the 200-day moving average. The market capitalization of the company currently stands at $13.63B.
The stock has received a hold rating from 3 analysts and a buy rating from 12. Brokers who have rated the stock have averaged $27.00 as their price target over the next twelve months.
With the price target maintained at $28, Citigroup recently Upgraded its rating from Neutral to Buy for Avantor Inc. (NYSE: AVTR). On September 14, 2022, Cowen Downgraded its previous ‘Outperform’ rating to ‘Market Perform’ on the stock reducing its target price from $39 to quote $28, while ‘Cleveland Research’ rates the stock as ‘Neutral’.
In other news, Stubblefield Michael, CEO bought 15,000 shares of the company’s stock on Nov 16. The stock was bought for $314,250 at an average price of $20.95. Upon completion of the transaction, the CEO now directly owns 429,500 shares in the company, valued at $8.97 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 16, EVP & CFO Szlosek Thomas A bought 12,500 shares of the business’s stock. A total of $258,850 was incurred on buying the stock at an average price of $20.71. This leaves the insider owning 35,668 shares of the company worth $0.74 million. Insiders disposed of 592,960 shares of company stock worth roughly $12.38 million over the past 1 year. A total of 0.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in AVTR stock. A new stake in Avantor Inc. shares was purchased by T. ROWE PRICE INVESTMENT MANAGEMENT, INC. during the first quarter worth $1,202,984,000. NEW MOUNTAIN CAPITAL, L.L.C. invested $292,320,000 in shares of AVTR during the first quarter. In the first quarter, MAVERICK CAPITAL LTD acquired a new stake in Avantor Inc. valued at approximately $127,992,000. EMINENCE CAPITAL, LP acquired a new stake in AVTR for approximately $98,440,000. MARSHALL WACE, LLP purchased a new stake in AVTR valued at around $27,700,000 in the second quarter. In total, there are 690 active investors with 91.80% ownership of the company’s stock.
On Friday morning Avantor Inc. (NYSE: AVTR) stock kicked off with the opening price of $21.13. During the past 12 months, Avantor Inc. has had a low of $17.91 and a high of $42.48. As of last week, the company has a debt-to-equity ratio of 1.35, a current ratio of 1.60, and a quick ratio of 1.10. The fifty day moving average price for AVTR is $20.70 and a two-hundred day moving average price translates $28.55 for the stock.
The latest earnings results from Avantor Inc. (NYSE: AVTR) was released for Jun, 2022. According to the Specialty Chemicals Company, earnings per share came in at $0.37, missing analysts’ expectations of $0.38 by -0.01. This compares to $0.26 EPS in the same period last year. The net profit margin was 7.80% and return on equity was 15.30% for AVTR. The company reported revenue of $1.86 billion for the quarter, compared to $1.83 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 1.21 percent. For the current quarter, analysts expect AVTR to generate $1.85B in revenue.
In terms of dividend payout ratio, AVTR is presently at 83.00%.
Avantor Inc.(AVTR) Company Profile
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.